Literature DB >> 17035635

Extracellular signal-regulated kinase 1/2 activity is not required in mammalian cells during late G2 for timely entry into or exit from mitosis.

Mio Shinohara1, Alexei V Mikhailov, Julio A Aguirre-Ghiso, Conly L Rieder.   

Abstract

Extracellular signal-regulated kinase (ERK)1/2 activity is reported to be required in mammalian cells for timely entry into and exit from mitosis (i.e., the G2-mitosis [G2/M] and metaphase-anaphase [M/A] transitions). However, it is unclear whether this involvement reflects a direct requirement for ERK1/2 activity during these transitions or for activating gene transcription programs at earlier stages of the cell cycle. To examine these possibilities, we followed live cells in which ERK1/2 activity was inhibited through late G2 and mitosis. We find that acute inhibition of ERK1/2 during late G2 and through mitosis does not affect the timing of the G2/M or M/A transitions in normal or transformed human cells, nor does it impede spindle assembly, inactivate the p38 stress-activated checkpoint during late G2 or the spindle assembly checkpoint during mitosis. Using CENP-F as a marker for progress through G2, we also show that sustained inhibition of ERK1/2 transiently delays the cell cycle in early/mid-G2 via a p53-dependent mechanism. Together, our data reveal that ERK1/2 activity is required in early G2 for a timely entry into mitosis but that it does not directly regulate cell cycle progression from late G2 through mitosis in normal or transformed mammalian cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17035635      PMCID: PMC1679686          DOI: 10.1091/mbc.e06-04-0284

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  71 in total

Review 1.  The p38-mediated stress-activated checkpoint. A rapid response system for delaying progression through antephase and entry into mitosis.

Authors:  Alexei Mikhailov; Mio Shinohara; Conly L Rieder
Journal:  Cell Cycle       Date:  2005-01-11       Impact factor: 4.534

2.  FoxM1 is required for execution of the mitotic programme and chromosome stability.

Authors:  Jamila Laoukili; Matthijs R H Kooistra; Alexandra Brás; Jos Kauw; Ron M Kerkhoven; Ashby Morrison; Hans Clevers; René H Medema
Journal:  Nat Cell Biol       Date:  2005-01-16       Impact factor: 28.824

3.  Proteome analysis of human metaphase chromosomes.

Authors:  Susumu Uchiyama; Shouhei Kobayashi; Hideaki Takata; Takeshi Ishihara; Naoto Hori; Tsunehito Higashi; Kayoko Hayashihara; Takefumi Sone; Daisuke Higo; Takashi Nirasawa; Toshifumi Takao; Sachihiro Matsunaga; Kiichi Fukui
Journal:  J Biol Chem       Date:  2005-01-31       Impact factor: 5.157

4.  Mitotic inactivation of a human SWI/SNF chromatin remodeling complex.

Authors:  S Sif; P T Stukenberg; M W Kirschner; R E Kingston
Journal:  Genes Dev       Date:  1998-09-15       Impact factor: 11.361

5.  Characterization of Raf-1 activation in mitosis.

Authors:  A D Laird; D K Morrison; D Shalloway
Journal:  J Biol Chem       Date:  1999-02-12       Impact factor: 5.157

6.  DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis.

Authors:  Jirina Bartkova; Zuzana Horejsí; Karen Koed; Alwin Krämer; Frederic Tort; Karsten Zieger; Per Guldberg; Maxwell Sehested; Jahn M Nesland; Claudia Lukas; Torben Ørntoft; Jiri Lukas; Jiri Bartek
Journal:  Nature       Date:  2005-04-14       Impact factor: 49.962

7.  Raf/MEK/MAPK signaling stimulates the nuclear translocation and transactivating activity of FOXM1c.

Authors:  Richard Y M Ma; Tommy H K Tong; Alice M S Cheung; Anthony C C Tsang; Wai Ying Leung; Kwok-Ming Yao
Journal:  J Cell Sci       Date:  2005-01-25       Impact factor: 5.285

Review 8.  Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human.

Authors:  C Widmann; S Gibson; M B Jarpe; G L Johnson
Journal:  Physiol Rev       Date:  1999-01       Impact factor: 37.312

9.  Activation of the MKK/ERK pathway during somatic cell mitosis: direct interactions of active ERK with kinetochores and regulation of the mitotic 3F3/2 phosphoantigen.

Authors:  P S Shapiro; E Vaisberg; A J Hunt; N S Tolwinski; A M Whalen; J R McIntosh; N G Ahn
Journal:  J Cell Biol       Date:  1998-09-21       Impact factor: 10.539

10.  Active MAP kinase in mitosis: localization at kinetochores and association with the motor protein CENP-E.

Authors:  M Zecevic; A D Catling; S T Eblen; L Renzi; J C Hittle; T J Yen; G J Gorbsky; M J Weber
Journal:  J Cell Biol       Date:  1998-09-21       Impact factor: 10.539

View more
  15 in total

Review 1.  Mitosis in vertebrates: the G2/M and M/A transitions and their associated checkpoints.

Authors:  Conly L Rieder
Journal:  Chromosome Res       Date:  2011-04       Impact factor: 5.239

2.  Quantitative site-specific phosphorylation dynamics of human protein kinases during mitotic progression.

Authors:  Kalyan Dulla; Henrik Daub; Renate Hornberger; Erich A Nigg; Roman Körner
Journal:  Mol Cell Proteomics       Date:  2010-01-23       Impact factor: 5.911

3.  RHAMM promotes interphase microtubule instability and mitotic spindle integrity through MEK1/ERK1/2 activity.

Authors:  Cornelia Tolg; Sara R Hamilton; Lyndsey Morningstar; Jing Zhang; S Zhang; Kenneth V Esguerra; Patrick G Telmer; Len G Luyt; Rene Harrison; James B McCarthy; Eva A Turley
Journal:  J Biol Chem       Date:  2010-06-17       Impact factor: 5.157

4.  The activity of extracellular signal-regulated kinase is required during G2/M phase before metaphase-anaphase transition in synchronized leukemia cell lines.

Authors:  Katarina Matkovic; Vesna Lukinovic-Skudar; Hrvoje Banfic; Dora Visnjic
Journal:  Int J Hematol       Date:  2009-01-17       Impact factor: 2.490

5.  The G2 p38-mediated stress-activated checkpoint pathway becomes attenuated in transformed cells.

Authors:  Alexei Mikhailov; Daksha Patel; Dennis J McCance; Conly L Rieder
Journal:  Curr Biol       Date:  2007-11-29       Impact factor: 10.834

6.  The ability to survive mitosis in the presence of microtubule poisons differs significantly between human nontransformed (RPE-1) and cancer (U2OS, HeLa) cells.

Authors:  Daniela A Brito; Conly L Rieder
Journal:  Cell Motil Cytoskeleton       Date:  2009-08

7.  MAPK pathway activation delays G2/M progression by destabilizing Cdc25B.

Authors:  Puji Astuti; Tanya Pike; Charlotte Widberg; Elizabeth Payne; Angus Harding; John Hancock; Brian Gabrielli
Journal:  J Biol Chem       Date:  2009-10-01       Impact factor: 5.157

8.  Increased susceptibility of breast cancer cells to stress mediated inhibition of protein synthesis.

Authors:  Shehla Pervin; An H Tran; Shaghayegh Zekavati; Jon M Fukuto; Rajan Singh; Gautam Chaudhuri
Journal:  Cancer Res       Date:  2008-06-15       Impact factor: 12.701

9.  Mechanisms of aneuploidy induction by RAS and RAF oncogenes.

Authors:  Tamihiro Kamata; Catrin Pritchard
Journal:  Am J Cancer Res       Date:  2011-03-29       Impact factor: 6.166

10.  Erk1/2 MAP kinases are required for epidermal G2/M progression.

Authors:  Phillip A Dumesic; Florence A Scholl; Deborah I Barragan; Paul A Khavari
Journal:  J Cell Biol       Date:  2009-05-04       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.